[:no]PhD-grader fra NCGC[:en]NCGC PhD dissertations[:]
[:no][et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
[/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
NCGC-prosjektene inkluderer tre doktorgrader, hvorav to nå er fullført. Avhandlingene vil bli gjort tilgjengelig på duo.uio.no når alle data er endelig publisert i vitenskapelige tidsskrifter. En PhD-grad innen helseøkonomi er fortsatt under arbeid.
MSc Robert Hanes ved Tumorbiologisk seksjon, Institutt for kreftforskning (OUS – Radiumhospitalet) forsvarte sin avhandling “Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma” 25/1-18. Opponenter var Dr. Sandra Strauss, University College London (UCL) Cancer Institute, London, Group leader Antoni Wiedlocha, Oslo University Hospital, og Professor emeritus Tom Kristensen, University of Oslo.
MA Isabelle Sylvie Budin Ljøsne ved Institutt for helse og samfunn (UiO) forsvarte sin PhD-avhandling “Bringing personalized medicine to people” 27/4-18. Opponenter var Dr. Eric Meslin, President and CEO, Council of Canadian Academies, Professor Effy Vayena, Institute of Translational Medicine, Eidgenössische Technische Hochschule (ETH) Zürich, og Professor Emeritus Gerd Holmboe-Ottesen, Institutt for helse og samfunn, Universitetet i Oslo.
Les intervju med Isabelle på Forskning.no
[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Nyhetsarkiv og konferanser” orientation=”left” area=”primary” background_layout=”light” remove_border=”off”]
[/et_pb_sidebar][/et_pb_column][/et_pb_row][/et_pb_section][:en][et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
[/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
The NCGC grants included three PhD projects, of which two are now completed. The theses will be available on duo.uio.no when all results have been published in scientific journals. Our PhD in health economy is not yet finished.
MSc Robert Hanes at the Dept of Tumour Biology, Institute for cancer Research (OUS – Radiumhospitalet) defended his thesis “Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma” 25/1-18. Opponents were Dr. Sandra Strauss, University College London (UCL) Cancer Institute, London, Group leader Antoni Wiedlocha, Oslo University Hospital, and Professor emeritus Tom Kristensen, University of Oslo.
MA Isabelle Sylvie Budin Ljøsne at the Institute for Healthe and Society (UiO) defended her PhD thesis “Bringing personalized medicine to people” 27/4-18. Opponents were Dr. Eric Meslin, President and CEO, Council of Canadian Academies, Professor Effy Vayena, Institute of Translational Medicine, Eidgenössische Technische Hochschule (ETH) Zürich, and Professor Emeritus Gerd Holmboe-Ottesen, Institutt for helse og samfunn, Universitetet i Oslo.
You may read interview of Isabelle at Forskning.no (Norwegian)
[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Nyhetsarkiv og konferanser” orientation=”left” area=”primary” background_layout=”light” remove_border=”off”]
[/et_pb_sidebar][/et_pb_column][/et_pb_row][/et_pb_section][:]